Atlas Trials

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Clinical trial NCT00122655 · TERMINATED

Trial details

NCT number
NCT00122655
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionsHIV Lipodystrophy Syndrome
Start date
2001-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.